Combination therapy using transferrin fusion proteins comprising GLP-1
摘要
The present invention provides combination therapy comprising transferrin fusion protein and DPP-IV inhibitors and/or neutral endopeptidase (NEP) inhibitors. The transferrin fusion protein comprises therapeutic polypeptides or peptides useful in the treatment of diseases such as diabetes.
申请公布号
ZA200701484(B)
申请公布日期
2008.07.30
申请号
ZA20070001484
申请日期
2005.08.03
申请人
BIOREXIS PHARMACEUTICAL CORPORATION
发明人
SADEGHI, HOMAYOUN;PRIOR, CHRISTOPHER;BALLANCE, DAVID J.